Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending September 13, 2006. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding Ordinary Shares of the Company.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory disclosure of share transactions and does not contain financial performance data.
Material Changes
The filing details specific transfers of Ordinary Shares from the GlaxoSmithKline Employee Trust ("GSK Trust") to participants in the SmithKline Beecham Employee Share Option Plan 1991:
- September 11, 2006: Transfer of 8,604 Ordinary Shares.
- September 13, 2006: Transfer of 32,116 Ordinary Shares.
Three directors (Dr J-P Garnier, Dr M M Slaoui, and Mr J S Heslop) are noted as having an interest in the shares held in the GSK Trust in the same capacity as other employees.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the notification of the aforementioned share transactions in accordance with Disclosure Rule 3.1.4R(1)(b).
Investor Verification Points
- Verify the total number of shares transferred to the SmithKline Beecham Employee Share Option Plan 1991 during the reporting period (40,720 shares total).
- Confirm the status of the GSK Trust as a discretionary trust for current and former employees.
- Note that this filing does not impact the company's financial statements or operational outlook.